Close Menu

Proteomics & Protein Research

News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.

UK-based Abcam has also taken an undisclosed equity stake in BrickBio, located in Boston, and will work with the company to further develop its platform.

The firm reported $14.9 million in revenue, driven by an 80 percent increase in product revenues, beating Wall Street expectations.

The collaborators are developing a sample prep solution for the Mission Bio Tapestri platform and are working on a hematology-focused panel.

The researchers suggested that the system's combination of speed and high coverage could enable new applications within the imaging mass spec space.

Fluidigm logged $26.4 million in revenues compared to $29.0 million a year ago and well short of analysts' consensus estimate of $28.7 million.

Veritas Genetics confirms a data breach of a customer-facing portal.

The federal government sues Gilead over prophylactic use of HIV drugs.

Gene expression shifts in stem cell-derived cardiomyocytes sent to space.

From Rome's history to a genetic screen for vulnerabilities in small cell lung cancer.

Nov
18
Sponsored by
Mission Bio

This webinar will outline the results of a study that performed integrative single-cell genome and cell surface protein expression profiling of adult acute myeloid leukemia (AML) cases. 

Nov
19
Sponsored by
Stilla

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.